Literature DB >> 17086179

A rigorous experimental framework for detecting protein oligomerization using bioluminescence resonance energy transfer.

John R James1, Marta I Oliveira, Alexandre M Carmo, Andrea Iaboni, Simon J Davis.   

Abstract

Bioluminescence resonance energy transfer (BRET), which relies on nonradiative energy transfer between luciferase-coupled donors and GFP-coupled acceptors, is emerging as a useful tool for analyzing the quaternary structures of cell-surface molecules. Conventional BRET analyses are generally done at maximal expression levels and single acceptor/donor ratios. We show that under these conditions substantial energy transfer arises from random interactions within the membrane. The dependence of BRET efficiency on acceptor/donor ratio at fixed surface density, or expression level at a defined acceptor/donor ratio, can nevertheless be used to correctly distinguish between well-characterized monomeric and oligomeric proteins, including a very weak dimer. The pitfalls associated with the nonrigorous treatment of BRET data are illustrated for the case of G protein-coupled receptors (GPCRs) proposed to form homophilic and/or mixed oligomers on the basis of previous, conventional BRET experiments.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17086179     DOI: 10.1038/nmeth978

Source DB:  PubMed          Journal:  Nat Methods        ISSN: 1548-7091            Impact factor:   28.547


  124 in total

Review 1.  Biased signalling and allosteric machines: new vistas and challenges for drug discovery.

Authors:  Terry P Kenakin
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  Effect of homomeric P450-P450 complexes on P450 function.

Authors:  James R Reed; J Patrick Connick; Dongmei Cheng; George F Cawley; Wayne L Backes
Journal:  Biochem J       Date:  2012-09-15       Impact factor: 3.857

3.  Third-party bioluminescence resonance energy transfer indicates constitutive association of membrane proteins: application to class a g-protein-coupled receptors and g-proteins.

Authors:  Sudhakiranmayi Kuravi; Tien-Hung Lan; Arnab Barik; Nevin A Lambert
Journal:  Biophys J       Date:  2010-05-19       Impact factor: 4.033

4.  Comparison between whole distribution- and average-based approaches to the determination of fluorescence resonance energy transfer efficiency in ensembles of proteins in living cells.

Authors:  Deo R Singh; Valerică Raicu
Journal:  Biophys J       Date:  2010-05-19       Impact factor: 4.033

Review 5.  Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.

Authors:  Terry Kenakin; Laurence J Miller
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

6.  Physical and functional interaction between CB1 cannabinoid receptors and beta2-adrenoceptors.

Authors:  Brian D Hudson; Terence E Hébert; Melanie E M Kelly
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

7.  Monomeric G protein-coupled receptor rhodopsin in solution activates its G protein transducin at the diffusion limit.

Authors:  Oliver P Ernst; Verena Gramse; Michael Kolbe; Klaus Peter Hofmann; Martin Heck
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

8.  Dopamine D2 receptors form higher order oligomers at physiological expression levels.

Authors:  Wen Guo; Eneko Urizar; Michaela Kralikova; Juan Carlos Mobarec; Lei Shi; Marta Filizola; Jonathan A Javitch
Journal:  EMBO J       Date:  2008-09-03       Impact factor: 11.598

9.  Rescue of defective G protein-coupled receptor function in vivo by intermolecular cooperation.

Authors:  Adolfo Rivero-Müller; Yen-Yin Chou; Inhae Ji; Svetlana Lajic; Aylin C Hanyaloglu; Kim Jonas; Nafis Rahman; Tae H Ji; Ilpo Huhtaniemi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-11       Impact factor: 11.205

10.  Specific oligomerization of the 5-HT1A receptor in the plasma membrane.

Authors:  Andrew Woehler; Jakub Wlodarczyk; Evgeni G Ponimaskin
Journal:  Glycoconj J       Date:  2008-10-14       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.